Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1657, 2008-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab affirms QOL improvement in MS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 502, 2006-01 ,pp. :
Access to resources
Recommend
Ocrelizumab + methotrexate well tolerated in RA
Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. :
Enalapril for heart failure well tolerated
Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. :
`Norplant' well tolerated in developing countries
Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. :
Natalizumab doing well outside phase III trials
Reactions Weekly, Vol. 1, Iss. 1275, 2009-01 ,pp. :